Nanjing Sinolife United Co., Ltd. Class H AI Stock Analysis
Want to see HK:3332 full AI Analyst Report?
Nanjing Sinolife United Co., Ltd. Class H (3332) AI Stock Analysis
Nanjing Sinolife United Co., Ltd. Class H
(HKEX:3332)
The score is driven primarily by mid-range financial performance: strong revenue scale-up and high gross margin are offset by sharp post-2023 margin compression and uneven cash flow consistency. Technical signals are moderately positive (price above shorter-term averages with positive MACD), while valuation is supportive with a low P/E.
Nanjing Sinolife United Co., Ltd. Class H (3332) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 131.54M
- Dividend Yield
- ―
- Average Volume (3M)
- 148.63K
- Price to Earnings (P/E)
- 6.1
- Beta (1Y)
- -0.19
- Revenue Growth
- 21.23%
- EPS Growth
- 24.06%
- Country
- Hong Kong
- Employees
- 533
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Medical - Pharmaceuticals
Nanjing Sinolife United Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Nanjing Sinolife United Company Limited functions as an investment holding entity primarily involved in the manufacturing, processing, and global distribution of nutritional supplements. Its operations span the People's Republic of China, Australia,...
Nanjing Sinolife United Co., Ltd. Class H Financial Statement Overview
Summary
Solid revenue growth over 2020–2025 and strong gross margin (~73% in 2025) support fundamentals, but profitability has deteriorated meaningfully since the 2023 peak (net margin down to ~3.2% in 2025) and cash flow has been volatile despite a strong 2025 rebound.
Income Statement
68PositiveBalance Sheet
70PositiveCash Flow
62Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 827.44M | 772.93M | 747.90M | 563.96M | 274.85M | 252.32M |
| Gross Profit | 626.68M | 566.18M | 538.27M | 379.66M | 160.00M | 138.80M |
| EBITDA | 36.53M | 34.87M | 51.86M | 75.08M | 4.88M | -13.49M |
| Net Income | 19.47M | 24.66M | 34.56M | 52.60M | -14.25M | -31.71M |
Balance Sheet | ||||||
| Total Assets | 695.27M | 603.72M | 505.56M | 505.42M | 436.99M | 390.11M |
| Cash, Cash Equivalents and Short-Term Investments | 309.78M | 240.36M | 104.53M | 122.79M | 78.19M | 76.23M |
| Total Debt | 191.24M | 107.24M | 33.90M | 35.16M | 35.75M | 8.87M |
| Total Liabilities | 278.30M | 186.58M | 111.46M | 127.35M | 113.19M | 59.87M |
| Stockholders Equity | 416.97M | 417.14M | 394.10M | 378.07M | 323.80M | 330.24M |
Cash Flow | ||||||
| Free Cash Flow | 51.84M | 64.92M | -6.65M | 44.76M | 4.05M | -9.68M |
| Operating Cash Flow | 56.45M | 68.63M | 957.00K | 47.11M | 7.92M | 421.00K |
| Investing Cash Flow | -1.89M | -725.00K | -6.00M | 449.00K | -3.47M | 1.52M |
| Financing Cash Flow | -50.59M | 11.84M | -4.53M | -4.50M | -4.08M | -4.45M |
Nanjing Sinolife United Co., Ltd. Class H Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3332, the sentiment is Negative. The current price of 0.15 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.17, and below the 200-day MA of 0.24, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 40.11 is Neutral, neither overbought nor oversold. The STOCH value of 58.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3332.
Nanjing Sinolife United Co., Ltd. Class H Peers Comparison
Overall Rating
HK:104475Outperform
HK:214571Outperform
HK:382870.4Outperform
HK:333269Neutral
HK:015745Neutral
HK:699341Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | HKD 25.79B | 8.94 | 10.98% | 7.21% | 2.19% | 10.78% | |
| 71Outperform | HKD 9.32B | 11.55 | 25.77% | 6.00% | 23.19% | -22.44% | |
| 70Outperform | HKD 473.75M | 5.57 | 6.06% | 10.00% | 2.24% | -39.98% | |
| 69Neutral | HKD 241.40M | 6.14 | 4.67% | ― | 21.23% | 24.06% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 45Neutral | HKD 860.90M | -14.98 | -12.81% | ― | 13.43% | 7.72% | |
| 41Neutral | HKD 16.10B | -176.52 | -1.21% | 6.22% | -2.44% | 81.73% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:3332 | Nanjing Sinolife United Co., Ltd. Class H | 0.15 | -0.21 | -58.61% | |
| HK:1044 | Hengan International Group Co | 22.22 | -3.82 | -14.65% | |
| HK:3828 | Ming Fai International Holdings | 0.65 | -0.22 | -25.46% | |
| HK:0157 | Natural Beauty Bio-Technology | 0.43 | -0.08 | -15.69% | |
| HK:2145 | Shanghai Chicmax Cosmetics Co., Ltd. Class H | 23.40 | -57.20 | -70.97% | |
| HK:6993 | Blue Moon Group Holdings Ltd. | 2.90 | 0.23 | 8.79% |
Nanjing Sinolife United Co., Ltd. Class H Corporate Events
Nanjing Sinolife Overhauls Governance and Uses Reserves to Clear Parent Losses
Shareholders of Nanjing Sinolife United Company Limited approved, by unanimous poll at an extraordinary general meeting on 4 September 2026, significant amendments to the company’s Articles of Association, including the abolition of its board of supe...
Nanjing Sinolife United Delivers Strong Revenue Growth but Lower Profit in First Half 2026
Nanjing Sinolife United Company Limited, a PRC-incorporated health and nutrition group listed in Hong Kong, reported solid top-line growth for the six months ended 30 June 2026. The business continues to focus on wellness products for consumers, with...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 24, 2026
